Genentech Beats Avastin Off-Label Injury Claims In Texas
A Texas judge on Thursday tossed design defect claims brought against Genentech Inc. by a patient who claims that a doctor injected him with the cancer drug Avastin as an off-label...To view the full article, register now.
Already a subscriber? Click here to view full article